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Abstract
Interaction of the local anesthetic dibucaine with small unilamellar vesicles of dimyristoylphosphatidylcholine (DMPC)
and dioleoyl phosphatidylcholine (DOPC) containing different mol percents of cholesterol has been studied by fluorescence
spectroscopy. Fluorescence measurements on dibucaine in presence of phospholipid vesicles containing various amounts of
cholesterol yielded a pattern of variation of wavelength at emission maximum and steady-state anisotropy which indicated
that the microenvironment of dibucaine is more polar and flexible in membranes that contain cholesterol than in membranes
without cholesterol. Experiments on quenching of fluorescence from membrane-associated dibucaine by potassium iodide
showed a marked increase in quenching efficiency as the cholesterol content of the vesicles was increased, demonstrating
increased accessibility of the iodide quenchers to dibucaine in the presence of cholesterol, when compared to that in its
absence. Total emission intensity decay profiles of dibucaine yielded two lifetime components of V1 ns and V2.8^3.1 ns
with mean relative contributions ofV25 andV75%, respectively. The mean lifetime in vesicles was 20^30% smaller than in
the aqueous medium and showed a moderate variation with cholesterol content. Fluorescence measurements at two different
temperatures in DMPC SUVs, one at 33‡C, above the phase transition temperature and another at 25‡C, around the main
phase transition, indicated two different mode of dibucaine localization. At 25‡C dibucaine partitioned differentially in
presence and absence of cholesterol. However, at 33‡C the apparent partition coefficients remained unaltered indicating
differences in the microenvironment of dibucaine in presence and absence of cholesterol in the phospholipid
membranes. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Tertiary amine local anesthetics cause anesthesia
by blocking nerve transmissions via state-dependent
binding of voltage-gated Na-channels [1,2]. How-
ever, whether this action is a result of speci¢c anes-
thetic^protein interaction or of nonspeci¢c perturba-
tion of the lipid bilayer structure is still an unsolved
question [1]. There are two major models of anes-
thetic action. The ¢rst of these, called the lipid hy-
pothesis, ascribes the e¡ect to physical alterations of
the lipid bilayer upon binding of the anesthetic to it.
The second, called the protein hypothesis, explains it
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in terms of direct speci¢c interaction of anesthetic
molecules with proteins [3^5]. According to this
view the interactions of local anesthetics with en-
zymes [6], membrane-bound acetylcholine receptor
[7] and Ca2-ATPase [8], or cytoskeletal proteins
which might have functional association with the
Na-channel [9], are believed to be relevant to their
mode of action. It is generally assumed that any one
of the above mentioned interactions with lipids and/
or membrane proteins can lead to the inactivation of
neuronal ion channel activity. However, interactions
with membrane lipids appear to be an important ¢rst
step for local anesthesia, since transbilayer move-
ment of the anesthetic molecule to the cytoplasmic
side of excitable membranes is a requirement for
anesthetic action [2,10].
Earlier studies on the partitioning of anesthetics,
to correlate potencies, in oil/water systems indicated
the site of action to be amphiphilic, and both aque-
ous potencies and lipid/water partition coe⁄cients
were well correlated with the hypothesis that mem-
brane lipids are the primary site for anesthetic action
[4,11]. Experimental observations of increase in sur-
face area, surface charge [12,13] and £uidity of phos-
pholipid membranes [14] upon addition of the anes-
thetics also supported the role of lipid matrix
structural alteration in the mode of action. The e¡ect
of local anesthetics on the organization of phospho-
lipid bilayers, and the motional constraints on the
anesthetic molecule upon binding to lipid mem-
branes, have been studied by several spectroscopic
and theoretical techniques [15^24].
One of the most widely studied tertiary amine local
anesthetics, dibucaine (2-butoxy-N-[2-diethylamino-
ethyl]-4-quinoline-carboxamine) can assume several
forms such as neutral base, hydrogen-bound, mono-
protonated, diprotonated and aggregated species,
depending upon the pH of the solvent and the nature
of the microenvironment [21]. It exists predominantly
in protonated monocationic form in a hydrophilic
environment, the equilibrium being shifted towards
the neutral form in hydrophobic environments.
NMR spectroscopic studies, supported by molecular
dynamics calculations, indicate that dibucaine as-
sumes more than two conformations and exists as
dimers in phosphatidylcholine (PC) vesicles [17].
In an earlier NMR study performed in pure PC
vesicles using deuterated anesthetics, multiple bind-
ing sites for tetracaine and procaine (two other ter-
tiary amine anesthetic molecules) were observed in
phospholipid bilayers [15]. These studies have also
indicated two states of binding for procaine and tet-
racaine: a ‘weakly bound’ state at a low pH of 5.5
and a ‘strongly bound’ state at a high pH of 9.5,
signifying the presence of two di¡erently charged or
aggregated species of the local anesthetics. There
have also been studies showing binding of cationic
dibucaine with negatively charged phospholipid
vesicles being favored by electrostatic contributions
[19,20]. Earlier £uorescence and NMR studies indi-
cated dibucaine binding in the vicinity of the phos-
pholipid glycerol moiety [16^19]. More recent studies
on depth pro¢ling by £uorescence quenching and
NMR investigations in di¡erent membrane systems
indicated the location of dibucaine to be at a shallow
position in the membrane bilayer [22^24].
Fewer attempts have been made to study the in-
teraction of dibucaine with speci¢c lipid components
of membranes other than PC. There has not been
any study on dibucaine interaction with cholesterol,
a ubiquitous component of the plasma membrane,
especially when excitable plasma membranes are
known to contain a relatively large amount of cho-
lesterol. NMR study has been done to study the
interaction of the local anesthetic tetracaine with
membranes containing PC and cholesterol [25]. We
report here a £uorescence study of the interaction of
dibucaine with small unilamellar vesicles (SUV’s) of
dimyristoylphosphatidylcholine (DMPC) and dio-
leoylphosphatidylcholine (DOPC) containing di¡er-
ent mol percents of cholesterol. Fluorescence tech-
niques have been previously used to study the
interaction of dibucaine with both zwitterionic and
acidic phospholipid model membranes, sarcoplasmic
reticulum vesicles and micellar systems [18^21,23,26].
Results from the present study indicate that localiza-
tion of dibucaine in phospholipid vesicles containing
cholesterol is di¡erent in the liquid crystalline phase
from that in vesicles containing no cholesterol. The
presence of cholesterol apparently creates a hin-
drance to the penetration of the local anesthetic mol-
ecules into the hydrophobic interior of the bilayer
resulting in its possible location closer to the lipid
head groups of the membranes. The present study
also demonstrates di¡erential dibucaine interaction
with a membrane containing cholesterol depending
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on the temperature, 25‡C, when the partitioning of
dibucaine is altered (near the DMPC phase transi-
tion) and at 33‡C, well above the phase transition
temperature of DMPC, when the apparent partition
coe⁄cient remains unaltered indicating an altered lo-
calization of the local anesthetic.
2. Materials and methods
Dibucaine hydrochloride, L-K-DMPC, L-K-DOPC,
cholesterol, potassium iodide (KI), diphenylhexa-
triene (DPH) and 3-[N-morpholino]propanesulfonic
acid (MOPS) were purchased from Sigma (St. Louis,
MO, USA). Deionized water, twice distilled on
quartz, was used for preparing solutions and bu¡ers.
Phospholipid concentrations were measured after di-
gestion with perchloric acid following a published
protocol [27]. Stock solutions of dibucaine and
DPH were prepared in ethanol and dimethylform-
amide, respectively and their concentrations deter-
mined by absorbance measurement on a Shimadzu
UV-2101PC spectrophotometer, using molar extinc-
tion coe⁄cients of 4400 M31 cm31 at 326 nm for
dibucaine and 88 000 M31cm31 at 350 nm for DPH
[18,28].
To prepare SUVs of DMPC and DOPC, solutions
of the phospholipids in chloroform were ¢rst evapo-
rated under a thin stream of nitrogen. The resulting
lipid ¢lms were then dried overnight in a vacuum
dessicator. Lipids were swollen by adding the bu¡er
containing 10 mM MOPS, pH 6.5, containing 50
mM NaCl to the ¢lms and the mixture was vortexed
to disperse the lipids. The dispersion was sonicated
for 10 min (in bursts of 1 min, while being cooled in
ice) using a Braun LabSonic 1510 sonicator. The
sonicated samples were centrifuged at 10 000 rpm
for 15 min to remove titanium particles. To prepare
cholesterol containing vesicles, appropriate quantities
of cholesterol were cosolubilized with the lipids in
chloroform:methanol (2:1 v/v). SUV’s composed of
PC alone and with cholesterol were characterized by
electron microscopy and were found to have average
diameters of V300 Aî . Cholesterol content in mem-
branes is expressed as mol percent with respect to the
phospholipid molar concentration.
Small aliquots of an ethanolic stock solution of
dibucaine hydrochloride were added to the standard
bu¡er to obtain typical ¢nal concentrations of 10 WM
for £uorescence measurements. Dibucaine £uores-
cence was measured on a Hitachi F-4010 spectro-
£uorometer using excitation at 325 nm and slits
with bandpasses of 5 nm for both excitation and
emission channels. Dibucaine-free vesicles were used
as reference blanks in absorption and emission mea-
surements to cancel any contribution from scattering
artifacts. Steady-state anisotropy was measured using
L-format optics. All measurements were performed
at 25‡C (except where mentioned) and with multiple
sets (3^5) of samples. Error bars were calculated as
standard errors of the mean. The temperature de-
pendences of £uorescence emission maxima of dibu-
caine and anisotropy of DPH in membrane environ-
ments were measured using a NESLAB RTE-110
circulating bath.
The apparent partition coe⁄cient (so called be-
cause electrostatic e¡ects were not taken into ac-
count) of dibucaine between the membrane and the
aqueous phases (Kp) was taken as the molar ratio of
lipid/drug at which the anisotropy vs. [L]/[D] plots
(Figs. 3 and 4) changed over from steeply increasing
to saturation behavior.
Fluorescence quenching measurements on dibu-
caine with iodide quencher were made by serial ad-
dition of small aliquots of concentrated (2 M) KI
solution to 1 ml of sample in a cuvette. Data were
¢tted to the Stern^Volmer equation:
F0=F corr  1 KSV Q 1
where Fcorr is the quenched intensity (corrected for
volume increase upon addition of quencher) and KSV
is the Stern^Volmer (dynamic) quenching constant.
Quenching plots in presence of membranes showed
saturation behavior at high quencher concentrations.
For these, KSV was determined by ¢tting the ¢rst ¢ve
data points to the linear relationship given by Eq. 1.
Plots exhibiting upward curvature (for dibucaine in
bu¡er) were ¢tted to the following modi¢ed form of
the Stern^Volmer equation using nonlinear least-
squares analysis [29]:
F0=F corr  1 KSV Q eV Q 2
where V is called the static quenching constant. Des-
ignated errors in KSV were the uncertainties of the
best-¢t parameters as given by the ¢tting program.
From the relation kq = KSV/Gdf, the bimolecular
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quenching rate constants were calculated where Gdf is
the mean excited state lifetime of dibucaine (Table 1).
Fluorescence lifetimes were determined from total
emission intensity decay measurements, using a time-
domain £uorometer assembled in our laboratory
with components from Edinburgh Analytical Instru-
ments (EIA, UK) and EGpGORTEC (USA) and
operated in the time-correlated single photon count-
ing mode. Excitation was provided by a pulsed high-
pressure (1.5 atmosphere) N2-lamp operating at 25
kHz repetition rate, the pulse pro¢le having a full
width at half maximum (FWHM) of 1.2 ns. The
£uorescence of dibucaine was excited at 325 nm,
while its emission intensity decay pro¢les in water
and in lipid vesicles were monitored at 412 nm and
402 nm, respectively. Monochromator slits with 16
nm bandpass were used for both excitation and emis-
sion. Typically, 5000 photon counts were accumu-
lated in the peak MCA channel for each lifetime
measurement, and two sets of data were collected
on each sample. Each intensity decay curve was ¢tted
to the sum-of-exponentials series:
It 
X
i
Ai exp3t=d i 3
where Ai is a pre-exponential factor representing the
fractional contribution to the time-resolved decay of
the component with a lifetime di. The decay param-
eters were recovered using a software package sup-
plied by EIA, implementing a nonlinear least-squares
iterative ¢tting procedure [30]. The mean (average)
lifetimes Gdf for bi-exponential decays were calculated
using the equation [29]:
Gd f 
X
i
K id i 4
where the fractional amplitude Ki corresponding to
the lifetime di is given by:
K i  Aid i=
X
i
Aid i 5
Errors in lifetime values were estimated from the
spread in individual lifetimes (di) obtained in repeti-
tive experiments on each sample.
3. Results
The emission maximum of dibucaine, which occurs
at 412 nm in pH 6.5 aqueous bu¡er (10 mM MOPS,
50 mM NaCl), shifts towards the blue in solutions
Fig. 1. Variation of wavelength at emission maximum (Vmax) of
dibucaine at 33‡C with phospholipid to dibucaine molar ratio
([L]/[D]) in SUV’s composed of (a) pure DMPC (a) and DMPC
with 10% (O) and 20% (E) cholesterol, and (b) pure DOPC
(a) and DOPC with 20% (O) and 40% (E) cholesterol.
Table 1
Quenching parameters for iodide quenching of dibucaine £uo-
rescence at 33‡C in aqueous medium and in DMPC and DOPC
vesicles containing varying amounts of cholesterol at lipid/dibu-
caine ratios of s 300 for DMPC and s 400 for DOPC
Medium KSV (M31) kq (M31 s31)
MOPS Bu¡er 42.0 þ 0.5 15.5 þ 0.3U109
DMPC 8.5 þ 0.3 3.80 þ 0.2U109
DMPC/10% cholesterol 17.3 þ 1.3 7.90 þ 0.6U109
DMPC/20% cholesterol 32.6 þ 0.8 15.0 þ 0.4U109
DOPC 4.1 þ 0.1 1.80 þ 0.4U109
DOPC/20% cholesterol 8.8 þ 0.4 4.10 þ 0.2U109
DOPC/40% cholesterol 14.9 þ 0.8 7.60 þ 0.4U109
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containing phospholipid vesicles. Fig. 1a shows the
change in wavelength of the emission maximum
(Vmax) as a function of the lipid to dibucaine molar
ratio ([L]/[D]) in presence of DMPC vesicles contain-
ing di¡erent amounts of cholesterol measured at
33‡C. In pure DMPC vesicles (for [L]/[D]s 400) the
maximum occurred at 394 nm, signifying a blue shift
of 18 nm. [L] is the molar concentration of lipid
phosphate and [D] being the same for dibucaine. In-
corporation of increasing amounts of cholesterol in
the DMPC vesicles had the e¡ect of progressively
decreasing this blue shift and the emission maxima
occurred at 401 and 406 nm when the vesicles con-
tained 10 and 20% cholesterol ([L]/[D]s 400), respec-
tively. At a ¢xed concentration of dibucaine, the blue
shift increased with increasing concentration of phos-
pholipid, i.e., with [L]/[D], to reach a saturation value.
Increasing the cholesterol content of the vesicles
from 0 to 20 mol percent produced a signi¢cant de-
crease of the blue shift, with the saturation value of
Vmax approaching that observed in aqueous bu¡er.
Fig. 1b shows the results of similar measurements
carried out in presence of DOPC vesicles at 33‡C.
Again, a signi¢cant blue shift (of 18 nm) was ob-
served with the pure lipid vesicles, which did not
change even when the vesicles contained up to 20%
cholesterol. At higher cholesterol contents the blue
shift decreased for 40% cholesterol the saturation
value of Vmax was 403 nm. Compared to the peak
intensity of emission from bulk aqueous medium,
that in presence of both DMPC and DOPC vesicles
decreased by up to 50% with increasing [L]/[D] as well
as with increasing cholesterol content. Fig. 2 shows
the temperature dependence of Vmax in DMPC
vesicles containing 0, 10 and 20% cholesterol. In all
cases the emission maximum shifted towards the blue
end with increase in temperature up to about 30‡C,
beyond which Vmax was nearly constant. All three
curves run parallel and look very similar, no e¡ect
being observed of the cholesterol content on the na-
ture of the variation.
Fig. 3. Variation of steady-state anisotropy of dibucaine with
[L]/[D] (a) at 33‡C and (b) at 25‡C in pure DMPC SUV’s (a)
and in DMPC SUV’s containing 10% (O) and 20% (E) choles-
terol. The errors in anisotropy are about the vertical size of in-
dividual data points.
Fig. 2. Temperature dependence of £uorescence emission maxi-
ma of dibucaine in SUV’s of pure DMPC (a, [L]/[D] = 400)
and DMPC containing 10% (O, [L]/[D] = 300) and 20%
(E, [L]/[D] = 200) cholesterol. Lines show the trends of the data.
BBAMEM 78050 1-3-01
M. Mondal et al. / Biochimica et Biophysica Acta 1511 (2001) 146^155150
Fluorescence anisotropy studies o¡er a convenient
method for obtaining information about the rota-
tional dynamics of a £uorophore. In aqueous solu-
tion the steady-state £uorescence anisotropy of free
dibucaine was measured to be very small
(0.008 þ 0.002), implying freedom of unhindered ro-
tational motion of the £uorophore. Incorporation in
DMPC vesicles produced a signi¢cant increase in
anisotropy (0.09 þ 0.01) at 33‡C (Fig. 3a), which
showed a steep initial increase with increasing
[L]/[D] before reaching saturation at higher lipid con-
tents both in presence and absence of cholesterol.
Fig. 3b shows similar anisotropy vs. [L]/[D] curves
at 25‡C showing higher magnitude of change in ani-
sotropy with lower cholesterol contents, indicating
that both the saturation value of the anisotropy
and the value of [L]/[D] at which saturation was at-
tained were larger for vesicles containing smaller
amounts of cholesterol. Fig. 4 shows the results of
similar experiments in DOPC vesicles at 25‡C, with
and without 20 and 40% cholesterol. As shown, the
anisotropy in presence of DOPC was smaller for
vesicles containing 40% cholesterol than for those
with 0 or 20% cholesterol. In DMPC vesicles, Tm
was determined by DPH anisotropy measurements
and was found to be 24‡C. Our measurements
showed a broadening of the DPH anisotropy vs.
temperature curve for DMPC membranes with in-
creasing amount of cholesterol. Above 10% choles-
terol we were unable to determine the Tm. A broader
transition around 30‡C was determined for vesicles
with 10% cholesterol, while the anisotropy was un-
altered in the range 13^40‡C for vesicles with 20%
cholesterol (data not shown).
Steady-state quenching of dibucaine £uorescence
by KI was measured in the MOPS bu¡er (pH 6.5)
and in presence of both types of lipid vesicles at
33‡C, without and with cholesterol, at [L]/[D] ratios
representing the saturation region of the plots in Fig.
1. Stern^Volmer plots of the quenching data are
shown in Fig. 5a for DMPC and Fig. 5b for
DOPC. The values of KSV obtained by ¢tting Eqs.
1 and 2 to these data and the quenching rate con-
stants are summarized in Table 1. In aqueous bu¡er
a nonlinear plot with upward curvature was ob-
tained, analysis of which yielded values of
(2.8 þ 0.1) M31 and (42 þ 0.5) M31 for the static
and dynamic (KSV) quenching constants, respectively.
The plot for dibucaine in pure DMPC vesicles at
Table 2
Total emission intensity decay parameters of dibucaine in aqueous bu¡er and in presence of DMPC and DOPC vesicles at 25‡C con-
taining various mol percents of cholesterol at lipid/dibucaine ratios of s 300 for DMPC and s 400 for DOPC
Medium d1 (ns) K1 (%) d2 (ns) K2 (%) Gdf (ns)
10 mM MOPS bu¡er, pH 6.5 3.13 78.6 1.16 21.4 2.71
Pure DMPC (no cholesterol) 2.77 71.2 0.94 28.8 2.24
DMPC+10% cholesterol 2.85 68.9 0.76 31.1 2.20
DMPC+20% cholesterol 2.92 66.0 0.84 28.6 2.17
Pure DOPC (no cholesterol) 2.77 73.7 0.77 26.3 2.24
DOPC+20% cholesterol 2.78 69.9 0.72 30.1 2.16
DOPC+40% cholesterol 2.80 62.3 0.60 37.7 1.97
Estimated errors in Gdf were þ 0.03 ns.
Fig. 4. Variation of steady-state anisotropy of dibucaine with
[L]/[D] at 25‡C in pure DOPC SUV’s (a) and in DOPC SUV’s
containing 20% (O) and 40% (E) cholesterol. The errors in ani-
sotropy are about the vertical size of individual data points.
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33‡C was linear but the quenching e⁄ciency of io-
dide was markedly lower than that in aqueous bu¡er,
with a KSV as low as (8.5 þ 0.3) M31. The quenching
e⁄ciency, however, increased with increasing
amounts of cholesterol incorporated in the vesicles,
as shown in Fig. 5a. In DMPC vesicles containing
20% cholesterol the value obtained for KSV was
about four times that obtained when the vesicles
contained no cholesterol. A drastic reduction of
quenching e⁄ciency was also observed in presence
of pure DOPC vesicles (Fig. 5b). However, in com-
parison to the case with DMPC vesicles, the e¡ect of
incorporating up to 20% cholesterol in DOPC
vesicles was smaller. An appreciable increase in KSV
took place for vesicles containing 40% cholesterol.
The quenching rate constants show similar changes
with the cholesterol content in DMPC and DOPC
vesicles summarized in Table 1.
Table 2 summarizes the results of time-resolved
measurement of total emission intensity decays of
dibucaine in bu¡er and in presence of the lipid
vesicles, with and without cholesterol at 25‡C. The
intensity pro¢les in all cases yielded good ¢ts to bi-
exponential decays. In MOPS bu¡er, pH 6.5 as well
as in presence of the membranes, the lifetimes were
characterized by a contribution (20^30%) from a
short-lived component (V1 ns) and another (70^
80%) from a longer-lived one (V3 ns). The value
of 2.7 ns obtained for the mean excited state lifetime
of dibucaine in bu¡er agrees reasonably well with the
lifetime in similar conditions reported by other work-
ers [19,31]. The relative magnitudes of the two com-
ponents did not change much but the mean lifetime
decreased by 20% in presence of the pure phospho-
lipid membranes, also in agreement with reported
results [19]. The mean lifetime decreased by V10%
with increase in cholesterol content of both DMPC
and DOPC vesicles.
4. Discussion
Previous NMR and £uorescence spectroscopic
studies have concluded that dibucaine binds in the
vicinity of the phospholipid glycerol moiety [16^19].
This location is in agreement with more recent stud-
ies placing the quinoline ring of dibucaine near the
glycerol [22^24]. The NMR study on the interaction
of the local anesthetic, tetracaine in DMPC vesicles
containing 30% cholesterol clearly suggested that the
location of tetracaine in a cholesterol containing sys-
tem is di¡erent from that in pure PC bilayer [25]. The
Table 3
Estimates of the apparent partition coe⁄cient (Kp) of dibucaine
in di¡erent membrane systems, with and without cholesterol
Medium 25‡C 33‡C
Pure DMPC (no cholesterol) 350 80
DMPC+10% cholesterol 200 70
DMPC+20% cholesterol 70 50
Pure DOPC (no cholesterol) 300
DOPC+20% cholesterol 300
DOPC+40% cholesterol 200
Fig. 5. Stern^Volmer plots of quenching of dibucaine £uores-
cence by iodide at 33‡C in (a) pH 6.5 bu¡er (10 mM MOPS,
50 mM NaCl and 1 mM sodium thiosulfate to prevent forma-
tion of I33 ) (O) and DMPC SUV’s containing 0% (a), 10%
(P) and 20% (E) cholesterol, and in (b) DOPC SUV’s contain-
ing 0% (a), 20% (P) and 40% (E) cholesterol.
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present study shows the e¡ects of cholesterol on the
partitioning and localization of dibucaine in the
SUVs of DMPC and DOPC.
The increase in anisotropy of dibucaine in presence
of phospholipid vesicles (Fig. 3) clearly points to the
imposition of constraints on the rotational freedom
of the £uorophore molecule, which in turn implies its
insertion into the bilayer membrane. Table 3 summa-
rizes the apparent partition coe⁄cient of dibucaine
between the membrane and aqueous phases (Kp), de-
termined as mentioned in Section 2, for the di¡erent
membrane systems under study. Kp was estimated to
be 80, 70 and 50 in DMPC vesicles at 33‡C contain-
ing 0, 10 and 20% cholesterol, respectively. In DOPC
membranes at 25‡C Kp was estimated to be about
300 for vesicles containing 0 and 20% cholesterol
and 200 for the same containing 40% cholesterol.
At 25‡C, near the main phase transition temperature
of DMPC, this value showed more signi¢cant change
with increasing cholesterol content in the mem-
branes. Thus Kp was estimated to be 350, 200 and
70 in DMPC vesicles at 25‡C containing 0, 10 and
20% cholesterol, respectively, indicating altered par-
titioning of dibucaine in the presence of cholesterol.
However, above the main phase transition temper-
atures of DMPC at 33‡C and in DOPC at 25‡C,
Kp did not change signi¢cantly up to 20% cholesterol
content, indicating displacement of dibucaine from
the interior towards the surface of the vesicles by
the presence of cholesterol. This is also consistent
with the study on localization of tetracaine that sug-
gested deeper partitioning in pure DMPC bilayer
while the presence of 30 mol percent cholesterol
‘squeezes’ it closer to the aqueous interface of the
bilayer [25].
Quenching of dibucaine £uorescence with iodide in
membrane systems containing di¡erent amounts of
cholesterol show that dibucaine is much less accessi-
ble to the iodide quencher in pure phospholipid
vesicles than in vesicles containing cholesterol at
33‡C (Fig. 5 and Table 1). This result implies that
dibucaine is located in the solvent-accessible region
around the lipid head-groups in cholesterol contain-
ing membranes, resulting in a large increase of acces-
sibility of the (predominantly) monocationic dibu-
caine by the anionic quencher. This is in good
agreement with the conclusion that while dibucaine
is embedded in the hydrophobic region of the bilayer
in pure phospholipid membranes, presence of choles-
terol inhibits the penetration of dibucaine molecules
deep into the bilayer.
Partitioning of dibucaine in the membrane phase is
also associated with a decrease in the quantum yield
of dibucaine (Table 2). This decrease in lifetime is
consistent with the decrease in the peak emission in-
tensity observed on transfer of dibucaine from bu¡er
solution to the membranes. That the inclusion of
cholesterol in DMPC vesicles does not a¡ect the
mean lifetime appreciably implies that the nature
and degree of this interaction remains more or less
unaltered in the process. The likely reason for the
observed decrease in its mean lifetime in vesicles,
measured at 25‡C, can be attributed to changes in
dibucaine partitioning in DMPC vesicles with and
without cholesterol. However, in DOPC membranes
the apparent partition coe⁄cient does not change
appreciably indicating that cholesterol brings about
a rearrangement of dibucaine inside the bilayer
rather than a¡ecting the partition equilibrium be-
tween the aqueous and lipid phases, at least in
DOPC membrane systems where the measurements
are done well above the phase transition temperature
of DOPC with Tm (318‡C) [32].
The interaction between cholesterol and PC has
been extensively studied and it is known to a¡ect
the phase transition between the liquid crystalline
and the ripple gel phases of PC membranes [32^36].
More recent evidence showed that there are other
types of lateral organization for membrane choles-
terol [37^40]. Our studies indicate that dibucaine
is located close to the aqueous interface in choles-
terol containing DMPC and DOPC bilayer vesicles
at 33‡C (above their Tm) where the partitioning
of dibucaine in the membrane phase is not signi¢-
cantly altered due to the presence of cholesterol.
The ‘condensing’ e¡ect of cholesterol is presumably
responsible in altering the localization site of the lo-
cal anesthetic dibucaine in membranes containing
cholesterol.
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